Bone Marrow Transplantation News

“Robust” federal funding is needed to build on recent advances in cancer research, ASCO’s senior vice president and chief medical officer, Richard L. Schilsky, MD, FASCO, said during a news conference on Capitol Hill on Wednesday.

Patients who underwent surgery for stage IV cancer experienced high rates of hospital readmissions, referrals to extended care facilities, morbidity and mortality, according to study results published in PLOS One.

Justin Taylor, MD, of Memorial Sloan Kettering Cancer Center and Roger Belizaire, MD, PhD, of Brigham and Women’s Hospital have been chosen to participate in the ASH–Harold Amos Medical Faculty Development Program.

ASH presented 2017 Scholar Awards to more than two dozen fellows and junior faculty who are dedicated to careers in hematology research.

Cancer mortality in the United States decreased by more than 20% from 1980 to 2014, according to a study conducted by researchers from University of Washington and published in JAMA.

The investigational hallucinogenic drug psilocybin reduced clinician- and patient-reported depression, anxiety and mortality-associated anxiety among adults with cancer, according to results of a small double blind study.

Salvage therapy with ibrutinib following allogeneic hematopoietic stem cell transplant conferred minimal residual disease negativity without causing graft-versus-host disease in patients with relapsed chronic lymphocytic leukemia, according to a study published in Blood.

Fewer than half of childhood cancer survivors receive recommended long-term follow-up care, according to findings of a study led by researchers at Roswell Park Cancer Institute.

The American Academy for Cancer Research released the first set of cancer genomic data from Project GENIE, a multiphase, international data-sharing effort.

A steady decline in smoking and advances in early detection and treatment have contributed to a 25% reduction in cancer death rates in the United States since 1991, according to Cancer Statistics 2017, the American Cancer Society’s comprehensive annual report on cancer incidence, mortality and survival.